Sanofi Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Sanofi stocks.

Sanofi Stocks Recent News

Date Stock Title
May 10 SNY Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
May 10 SNY Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
May 10 SNY Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
May 10 SNY Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
May 10 SNY Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
May 10 SNY Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
May 10 SNY Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
May 10 SNY Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
May 10 SNY These Stocks Are Moving the Most Today
May 10 SNY Stock markets, China tariffs, Novavax and Sanofi: 3 Things
May 10 SNY US STOCKS-Futures rise ahead of data, speeches from Fed officials
May 10 MRK Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years
May 10 REGN Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
May 10 SNY Novavax surges as Sanofi COVID vaccine deal boosts outlook
May 10 MRK Merck: The Worst Has Been Avoided (Rating Upgrade)
May 10 SNY Maze lands new partner for Pompe drug, after Sanofi pact came apart
May 10 SNY Trending tickers: TSMC, Novavax, Anglo American and IAG
May 10 SNY Novavax gets a lifeline with Sanofi vaccine pact
May 10 SNY Novavax Unveils Deal With Sanofi to Co-commercialize COVID-19 Vaccine, Develop Novel Medication
May 10 SNY UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Browse All Tags